X-COR Therapeutics Inc

Allston, MA · Founded 2018 · CIK 0001768464 · Medtech · Private

Extracorporeal CO2 removal (ECCO2R) device using dialysis-like filtration to remove carbon dioxide from blood in hypercapnic respiratory failure patients

xcormed.com →
Grants
$861K
3 awards
Sector median: 1
Raised
$200K
1 Form D · Feb 2019
92 months since last filing
Contracts
—
No federal contracts on record
Patents
4
1 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,002
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure.$293,121
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure.$293,121
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Respiratory dialysis for extracorporeal carbon dioxide treatment of COPD$274,274
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
830149 MEDICAL INC—$450K
831AMORPHEX THERAPEUTICS HOLDINGS INC.—$265K
832Neural Dynamics Technologies LLC—$240K
833X-COR Therapeutics Inc—$200K
834Surgical Training Simulators, Inc.—$200K
835Alexander International Innovations LLC—$200K
836HeartBeam, Inc.—$200K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Brian ChangDirector
  • Steven KellerDirector
  • Jayon WangDirector · Executive Officer · Promoter

Patents

USPTO · 1 granted of 4
  • Systems, Devices, And Methods For Extracorporeal Removal Of Carbon Dioxideapplication
  • Systems, Devices, And Methods For Extracorporeal Removal Of Carbon Dioxidegranted
  • Mass Transfer Device For The Treatment Of Biological Fluids And Methods Of Useapplication
  • Mass Transfer Device For The Treatment Of Biological Fluids And Methods Of Useapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.